<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04577274</url>
  </required_header>
  <id_info>
    <org_study_id>814/2562 (IRB3)</org_study_id>
    <nct_id>NCT04577274</nct_id>
  </id_info>
  <brief_title>Impact of High Protein and Low Carbohydrate Smoothie Drinks in Type-2 Diabetes Mellitus</brief_title>
  <official_title>Impact of High Protein and Low Carbohydrate Smoothie Drinks Versus Diabetes-specific Nutritional Formulas on Postprandial Glucose Homeostasis in Type-2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Council of Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We compared between a regular high protein or a high protein and low carbohydrate smoothie&#xD;
      drinks with conventional diabetic enteral drinks (Glucerna) on glucose homeostasis, insulin&#xD;
      and lipid metabolism in type 2 diabetic and obese individuals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We aimed to determine the effect of high protein and low carbohydrate smoothie drinks on&#xD;
      glucose homeostasis, insulin and lipid metabolism in type 2 diabetic and obese individuals.&#xD;
      We compared between a regular high protein or a high protein and low carbohydrate smoothie&#xD;
      drinks with conventional diabetic enteral drinks (Glucerna). A crossover design study was&#xD;
      done in 60 diabetic participants. Participants consumed 300 kilocalories of each drink at a&#xD;
      time with one week wash out period between drinks and glucose response curves at baseline,&#xD;
      30, 60, 90, 120, 180 and 240 minutes were monitored and compared. The products were&#xD;
      formulated to supply 1 kilocalorie/milliliter (kcal/ml). Dietary compositions in regular&#xD;
      formulas (smoothie, SM) were 30-40% carbohydrate, 20-30% protein and 30-50% fat. While in&#xD;
      smoothie with low carbohydrate formulas (SMLS), they were 25-35% carbohydrate, 25-30% protein&#xD;
      and 35-55% fat vs. a control formula (Glucerna).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 4, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Actual">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline Glycemia at 240 minutes</measure>
    <time_frame>Minutes after intake of each smoothie formula: 0, 30, 60, 90, 120, 180, 240</time_frame>
    <description>glucose (mg/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline Insulin at 240 minutes</measure>
    <time_frame>Minutes after intake of each smoothie formula: 0, 30, 60, 90, 120, 180, 240</time_frame>
    <description>insulin (Î¼U/ml)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Age</measure>
    <time_frame>Baseline</time_frame>
    <description>years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline</time_frame>
    <description>kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>Baseline</time_frame>
    <description>cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>Baseline</time_frame>
    <description>kg/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>Baseline</time_frame>
    <description>cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Baseline</time_frame>
    <description>Systolic and Diastolic blood pressure (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete Blood Count (CBC)</measure>
    <time_frame>Baseline</time_frame>
    <description>Red blood cells (RBC) [10^6 cells/ul], White blood cells (WBC) [10^3 cells/ul], Hemoglobin (HGB) [g/dL], Hematocrit (HCT) [%]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glycosylated hemoglobin (HbA1C)</measure>
    <time_frame>Baseline</time_frame>
    <description>percentage (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>liver aminotransferaces activity - Serum glutamate oxaloacetate transaminase (SGOT)</measure>
    <time_frame>Baseline</time_frame>
    <description>Serum glutamate oxaloacetate transaminase (SGOT) [U/L]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>liver aminotransferaces activity - Serum glutamate pyruvate transaminase (SGPT)</measure>
    <time_frame>Baseline</time_frame>
    <description>Serum glutamate pyruvate transaminase (SGPT) [U/L]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lipid profiles concentration analysis</measure>
    <time_frame>Baseline</time_frame>
    <description>Triglycerides (mg/dl), Cholesterol (mg/dl), HDL-Cholesterol (mg/dl) and LDL-Cholesterol (mg/dl)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine concentration analysis</measure>
    <time_frame>Baseline</time_frame>
    <description>mg/dl</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>smoothie with regular formulas (SM)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants were given 300 kcal smoothie with regular formulas within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>smoothie with low carbohydrate formulas (SMLS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants were given 300 kcal smoothie with low carbohydrate formulas within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional diabetic enteral drinks (Glucerna)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants were given 300 kcal Glucerna within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>smoothie with regular formulas (SM)</intervention_name>
    <description>Participants were given 300 kcal of smoothie drink within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes. Participants have one week wash out period before try-out other formulas.</description>
    <arm_group_label>smoothie with regular formulas (SM)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>smoothie with low carbohydrate formulas (SMLS)</intervention_name>
    <description>Participants were given 300 kcal of smoothie drink within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes. Participants have one week wash out period before try-out other formulas.</description>
    <arm_group_label>smoothie with low carbohydrate formulas (SMLS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>conventional diabetic enteral drinks (Glucerna)</intervention_name>
    <description>Participants were given 300 kcal of smoothie drink within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes. Participants have one week wash out period before try-out other formulas.</description>
    <arm_group_label>conventional diabetic enteral drinks (Glucerna)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. people with type 2 diabetes mellitus or use blood glucose-lowering drugs more than 3&#xD;
             months&#xD;
&#xD;
          2. BMI &gt; 25 kg/m^2&#xD;
&#xD;
          3. HbA1c 6.5 - 8.5&#xD;
&#xD;
          4. use stable level of blood glucose-lowering drugs and blood lipid-lowering drugs more&#xD;
             than 3 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. pregnancy or breastfeeding&#xD;
&#xD;
          2. people with chronic diseases or tube feeding or dysphagia i.e. pneumonia&#xD;
&#xD;
          3. people with insulin injection or use GLP-1 analogues drugs or DPP-4 inhibitors drugs&#xD;
&#xD;
          4. people with history of bariatric surgery, gastroparesis, malabsorption&#xD;
&#xD;
          5. people with history of diseases that affect blood glucose/lipid control i.e.&#xD;
             hyperthyroidism, endocrinology and kidney disorders&#xD;
&#xD;
          6. use long-term immunosuppressants&#xD;
&#xD;
          7. cancer patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Korapat Mayurasakorn, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Doctor in Family Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok Noi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>October 1, 2020</study_first_submitted>
  <study_first_submitted_qc>October 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2020</study_first_posted>
  <last_update_submitted>May 12, 2021</last_update_submitted>
  <last_update_submitted_qc>May 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>clinical nutrition</keyword>
  <keyword>smoothie drink</keyword>
  <keyword>meal replacement</keyword>
  <keyword>medical food</keyword>
  <keyword>diabetes</keyword>
  <keyword>obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

